MT Newswires on MSN15h
Eli Lilly Plans 4 New US Manufacturing Sites With $27 Billion Investment
Eli Lilly (LLY) on Wednesday outlined a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US. The pharmaceutical giant said that three of the planned ...
Eli Lilly shares climb for seven consecutive sessions
Eli Lilly (NYSE:LLY) shares soar, driven by strong growth in weight-loss drugs, major investments, and bullish analyst ratings.
InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Eli Lilly to boost U.S. manufacturing footprint amid Trump’s tariff threats
Eli Lilly (NYSE:LLY) announced plans to more than double its investments in domestic medicine production to over $50B on ...
BioPharma Dive21h
Lilly expands US manufacturing build-out with $50B target
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Truist Financial Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares ...
Eli Lilly pays $10m upfront for Organovo’s FXR agonist
Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...